NCCS Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner
NCCS applauds the nomination of Dr. Scott Gottlieb for commissioner of the FDA. Dr. Gottlieb’s experience as a physician, a policymaker, and a patient uniquely qualifies him to lead the FDA at this important time. The agency confronts a rich pipeline of new products for cancer and other illnesses, and ...
What Caught Our Eye: High-Risk Pools, “Trumpcare,” Childhood Cancer Survivors, Medicaid Spending, Trump’s FDA Deregulation
What Caught Our Eye (WCOE), March 3, 2017 What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. Affordable Care Act "States Be Warned: High-Risk Pools Offer Little Help At A High Cost" Do high-risk pools offer ...
What Caught Our Eye: GOP ACA Talking Points Analysis, Right to Try Op-Ed, “Worry, Scan, Treat, Repeat”
Kaiser Health News’ Julie Rovner analyzes key Republican talking points on the ACA. One concern consumers have is high out-of-pocket costs. But, Rovner writes, “Republicans’ most popular proposals for replacing current individual insurance plans — cutting back on required benefits and giving more people access to tax-preferred health savings accounts ...
Ask Your Oncologist About Clinical Drug Trials
If you had asked me in December 2012 if I would ever participate in a clinical drug trial, my answer would have been a resounding, “No.” The very word “trial” scared me off; I didn’t want to be a guinea pig, a test subject. I wanted proven medicine ...
Webinar Video: “Cancer Moonshot – Symptom Management and Funding”
This week, NCCS hosted the latest CPAT webinar, Cancer Moonshot: Symptom Management and Funding. The featured presenters were Deborah K. Mayer, PhD, RN, AOCN, FAAN; and MK Holohan, JD. Dr. Mayer is the Director of Cancer Survivorship at the UNC Lineberger Cancer Center and a member of the Cancer Moonshot ...
NCCS Comments on the FDA’s PDUFA Proposed Commitment Letter
NCCS submitted comments to the Food and Drug Administration (FDA) on the letter representing the agreement between FDA and regulated industry on goals for the re-authorization of the Prescription Drug User Fee Act (PDUFA VI). NCCS participated in the PDUFA stakeholder meetings held over the last year, and we support ...
WCOE: Traveling for Treatment, Bipartisan Cancer Policy, Some Tumors Evade Targeted Therapy, Treatment vs Hype, Clinical Trials Info
What Caught Our Eye (WCOE) Each week, we recap the cancer policy articles, studies, and stories that caught our attention. From @cure_magazine On the Road to Recovery: Traveling for #Cancer Treatment https://t.co/TFFijL2dpT #survivorship— NCCS - National Coalition for Cancer Survivorship (@CancerAdvocacy) March 9, 2016 Via @RollCall: #Cancer Experiences Could Help ...
WCOE: NCCS Moonshot Op-Ed, ACA Enrollment Deadline, Susan Gubar, BRCA Gene and Family, Poor Treatment Outcomes for Minorities
What Caught Our Eye (WCOE) Each week, we recap the cancer policy articles, studies, and stories that caught our attention. NCCS CEO @sfuldnasso op-ed in @TheHill on #CancerMoonshot: Three questions @VP Biden's team needs to answer. https://t.co/3NAGYoyfHQ— NCCS - National Coalition for Cancer Survivorship (@CancerAdvocacy) January 28, 2016 Still need ...
WCOE: Current Status of State Medicaid Expansion, Diversity of Clinical Trials, ACA Enrollment Deadline Extended
What Caught Our Eye (WCOE) Each week, we recap the cancer policy articles, studies, and stories that caught our attention. UPDATED #MedicaidExpansion map: Includes status changes for #Virginia & #Utah https://t.co/03PuV7IlHO pic.twitter.com/bAtfVjd1vs— KFF (Kaiser Family Foundation) (@KFF) December 17, 2015 Via @NPR: Clinical Trials Still Don't Reflect The Diversity Of ...
Dr. Julia Rowland Discusses the Importance of Psychosocial Care: Engagement and Dialogue
This post is part of our 20 Years Later blog series which examines progress in advancing the principles in the 1995 NCCS publication Imperatives for Quality Cancer Care: Access, Advocacy, Action, and Accountability(Imperatives). The eleventh principle states that “Psychosocial research is integral to comprehensive cancer care and, as such, psychosocial outcome measures should be ...
